Search

everythinglearnresearchcommunity

for

Search:↓

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Non-immune factors play a significant role in alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Genomic approach finds new possible treatments for hair loss.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Certain gene variations increase the risk of alopecia areata in Koreans.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

A genetic marker linked to a type of hair loss was found in most patients studied.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.